Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations-Reference-Cited by-同舟云学术

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

Published:2011-08-10 Issue:1 Volume:130 Page:145-153
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bayraktar Soley,Gutierrez-Barrera Angelica M.,Liu Diane,Tasbas Tunc,Akar Ugur,Litton Jennifer K.,Lin E.,Albarracin Constance T.,Meric-Bernstam Funda,Gonzalez-Angulo Ana M.,Hortobagyi Gabriel N.,Arun Banu K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1711-z.pdf

Reference58 articles.

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747–752

2. Rakha EA, Reis-Filho JS, Ellis IO (2008) Basal-like breast cancer: a critical review. J Clin Oncol 26:2568–2581

3. Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D (2008) How basal are triple-negative breast cancers? Int J Cancer 123:236–240

4. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482–1485

5. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175–5180

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status;BMC Medicine;2024-01-09

2. BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer;Cell Death Discovery;2024-01-05

3. Survival outcomes of patients with HER2/neu‐positive breast cancer with germline BRCA mutations;Cancer;2023-12-15

4. BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer;2023-09-28

5. BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy;Biomedicine & Pharmacotherapy;2023-02